Dipna Pharmachem Ltd (DPL) is currently trading at 4.74 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Dipna Pharmachem Limited focuses on the trading and distribution of pharmaceutical raw materials, specifically Active Pharmaceutical Ingredients (APIs) and intermediates. The company has transitioned from private to public limited status, as marked by its recent incorporation in May 2022. They successfully raised funds through an IPO in August 2022, enhancing their capital base by Rs 15.2 Cr via issuing equity shares. In FY 2022, Dipna Pharmachem expanded operations to include chemical trading, indicating an effort to diversify business. The company offers a wide portfolio of 61 APIs, covering various therapeutic areas, positioning its services across a pan-India market.

Over the past 52 weeks, Dipna Pharmachem Ltd has traded between a low of ₹3.90 and a high of ₹25.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Dipna Pharmachem Ltd has a market capitalization of approximately 12.22. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Dipna Pharmachem Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 4.65 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 12.22 Cr, Dipna Pharmachem Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Dipna Pharmachem Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Dipna Pharmachem Ltd is 4.65. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.